> top > projects > spacy-test > docs > PubMed:3923627 > annotations
TextAE configuration unavailable!
spacy-test Home  

PubMed:3923627 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-9 VBN denotes Increased
spaCy_T1 10-16 NNS denotes levels
spaCy_T2 17-19 IN denotes of
spaCy_T3 20-35 JJ denotes HDL-cholesterol
spaCy_T4 36-39 CC denotes and
spaCy_T5 40-54 JJ denotes apolipoprotein
spaCy_T6 55-58 NN denotes A-I
spaCy_T7 59-64 IN denotes after
spaCy_T8 65-76 VBN denotes intensified
spaCy_T9 77-84 NN denotes insulin
spaCy_T10 85-92 NN denotes therapy
spaCy_T11 93-96 IN denotes for
spaCy_T12 97-105 NN denotes diabetes
spaCy_T13 105-106 . denotes .
spaCy_T14 107-114 CD denotes Sixteen
spaCy_T15 115-123 NNS denotes subjects
spaCy_T16 124-128 IN denotes with
spaCy_T17 129-146 JJ denotes insulin-dependent
spaCy_T18 147-155 NN denotes diabetes
spaCy_T19 156-164 NN denotes mellitus
spaCy_T20 165-169 VBD denotes were
spaCy_T21 170-177 VBN denotes studied
spaCy_T22 178-180 TO denotes to
spaCy_T23 181-190 VB denotes determine
spaCy_T24 191-198 IN denotes whether
spaCy_T25 199-206 NNS denotes changes
spaCy_T26 207-209 IN denotes in
spaCy_T27 210-216 NN denotes plasma
spaCy_T28 217-223 NNS denotes lipids
spaCy_T29 224-227 CC denotes and
spaCy_T30 228-243 NNS denotes apolipoproteins
spaCy_T31 244-250 VBP denotes follow
spaCy_T32 251-262 VBN denotes intensified
spaCy_T33 263-270 NN denotes control
spaCy_T34 271-276 VBG denotes using
spaCy_T35 277-288 JJ denotes preprandial
spaCy_T36 289-294 NNS denotes doses
spaCy_T37 295-297 IN denotes of
spaCy_T38 298-305 JJ denotes regular
spaCy_T39 306-313 NN denotes insulin
spaCy_T40 314-318 IN denotes with
spaCy_T41 319-321 DT denotes an
spaCy_T42 322-332 JJ denotes additional
spaCy_T43 333-337 NN denotes dose
spaCy_T44 338-340 IN denotes of
spaCy_T45 341-344 NNP denotes NPH
spaCy_T46 345-352 NN denotes insulin
spaCy_T47 353-359 IN denotes before
spaCy_T48 360-367 NN denotes bedtime
spaCy_T49 367-368 . denotes .
spaCy_T50 369-372 DT denotes The
spaCy_T51 373-377 JJ denotes mean
spaCy_T52 378-383 JJ denotes total
spaCy_T53 384-389 NN denotes dialy
spaCy_T54 390-394 NN denotes dose
spaCy_T55 395-397 IN denotes of
spaCy_T56 398-405 NN denotes insulin
spaCy_T57 406-409 VBD denotes was
spaCy_T58 410-419 VBN denotes increased
spaCy_T59 420-424 IN denotes from
spaCy_T60 425-429 CD denotes 1.03
spaCy_T61 430-431 CD denotes +
spaCy_T62 431-432 SYM denotes /
spaCy_T63 432-433 : denotes -
spaCy_T64 434-438 CD denotes 0.09
spaCy_T65 439-441 TO denotes to
spaCy_T66 442-446 CD denotes 1.17
spaCy_T67 447-448 CD denotes +
spaCy_T68 448-449 SYM denotes /
spaCy_T69 449-450 : denotes -
spaCy_T70 451-455 CD denotes 0.44
spaCy_T71 456-464 NN denotes units/kg
spaCy_T72 465-475 IN denotes throughout
spaCy_T73 476-479 DT denotes the
spaCy_T74 480-489 JJ denotes six-month
spaCy_T75 490-496 NN denotes period
spaCy_T76 496-497 . denotes .
spaCy_T77 498-504 NNS denotes Levels
spaCy_T78 505-507 IN denotes of
spaCy_T79 508-523 JJ denotes HDL-cholesterol
spaCy_T80 524-527 CC denotes and
spaCy_T81 528-542 JJ denotes apolipoprotein
spaCy_T82 543-546 NNP denotes A-I
spaCy_T83 547-556 VBD denotes increased
spaCy_T84 557-564 IN denotes without
spaCy_T85 565-576 JJ denotes significant
spaCy_T86 577-584 NNS denotes changes
spaCy_T87 585-587 IN denotes in
spaCy_T88 588-598 NN denotes hemoglobin
spaCy_T89 599-601 NNP denotes A1
spaCy_T90 602-603 -LRB- denotes (
spaCy_T91 603-607 NNP denotes HbA1
spaCy_T92 607-608 -RRB- denotes )
spaCy_T93 608-609 , denotes ,
spaCy_T94 610-622 NN denotes triglyceride
spaCy_T95 622-623 , denotes ,
spaCy_T96 624-626 CC denotes or
spaCy_T97 627-638 NN denotes cholesterol
spaCy_T98 638-639 . denotes .
spaCy_T99 640-645 DT denotes These
spaCy_T100 646-654 NNS denotes findings
spaCy_T101 655-662 VBP denotes suggest
spaCy_T102 663-667 IN denotes that
spaCy_T103 668-677 NNS denotes increases
spaCy_T104 678-680 IN denotes in
spaCy_T105 681-696 JJ denotes HDL-cholesterol
spaCy_T106 697-700 CC denotes and
spaCy_T107 701-715 JJ denotes apolipoprotein
spaCy_T108 716-719 NNP denotes A-I
spaCy_T109 720-724 VBD denotes were
spaCy_T110 725-726 DT denotes a
spaCy_T111 727-733 NN denotes result
spaCy_T112 734-736 IN denotes of
spaCy_T113 737-740 DT denotes the
spaCy_T114 741-752 VBN denotes intensified
spaCy_T115 753-760 NN denotes insulin
spaCy_T116 761-769 NN denotes delivery
spaCy_T117 769-770 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 amod Increased,levels
spaCy_R1 spaCy_T1 spaCy_T1 ROOT levels,levels
spaCy_R10 spaCy_T10 spaCy_T7 pobj therapy,after
spaCy_R100 spaCy_T100 spaCy_T101 nsubj findings,suggest
spaCy_R101 spaCy_T101 spaCy_T101 ROOT suggest,suggest
spaCy_R102 spaCy_T102 spaCy_T109 mark that,were
spaCy_R103 spaCy_T103 spaCy_T109 nsubj increases,were
spaCy_R104 spaCy_T104 spaCy_T103 prep in,increases
spaCy_R105 spaCy_T105 spaCy_T108 amod HDL-cholesterol,A-I
spaCy_R106 spaCy_T106 spaCy_T105 cc and,HDL-cholesterol
spaCy_R107 spaCy_T107 spaCy_T105 conj apolipoprotein,HDL-cholesterol
spaCy_R108 spaCy_T108 spaCy_T104 pobj A-I,in
spaCy_R109 spaCy_T109 spaCy_T101 ccomp were,suggest
spaCy_R11 spaCy_T11 spaCy_T10 prep for,therapy
spaCy_R110 spaCy_T110 spaCy_T111 det a,result
spaCy_R111 spaCy_T111 spaCy_T109 attr result,were
spaCy_R112 spaCy_T112 spaCy_T111 prep of,result
spaCy_R113 spaCy_T113 spaCy_T116 det the,delivery
spaCy_R114 spaCy_T114 spaCy_T116 amod intensified,delivery
spaCy_R115 spaCy_T115 spaCy_T116 compound insulin,delivery
spaCy_R116 spaCy_T116 spaCy_T112 pobj delivery,of
spaCy_R117 spaCy_T117 spaCy_T101 punct .,suggest
spaCy_R12 spaCy_T12 spaCy_T11 pobj diabetes,for
spaCy_R13 spaCy_T13 spaCy_T1 punct .,levels
spaCy_R14 spaCy_T14 spaCy_T15 nummod Sixteen,subjects
spaCy_R15 spaCy_T15 spaCy_T21 nsubjpass subjects,studied
spaCy_R16 spaCy_T16 spaCy_T15 prep with,subjects
spaCy_R17 spaCy_T17 spaCy_T19 amod insulin-dependent,mellitus
spaCy_R18 spaCy_T18 spaCy_T19 compound diabetes,mellitus
spaCy_R19 spaCy_T19 spaCy_T16 pobj mellitus,with
spaCy_R2 spaCy_T2 spaCy_T1 prep of,levels
spaCy_R20 spaCy_T20 spaCy_T21 auxpass were,studied
spaCy_R21 spaCy_T21 spaCy_T21 ROOT studied,studied
spaCy_R22 spaCy_T22 spaCy_T23 aux to,determine
spaCy_R23 spaCy_T23 spaCy_T21 advcl determine,studied
spaCy_R24 spaCy_T24 spaCy_T31 mark whether,follow
spaCy_R25 spaCy_T25 spaCy_T31 nsubj changes,follow
spaCy_R26 spaCy_T26 spaCy_T25 prep in,changes
spaCy_R27 spaCy_T27 spaCy_T28 compound plasma,lipids
spaCy_R28 spaCy_T28 spaCy_T26 pobj lipids,in
spaCy_R29 spaCy_T29 spaCy_T28 cc and,lipids
spaCy_R3 spaCy_T3 spaCy_T2 pobj HDL-cholesterol,of
spaCy_R30 spaCy_T30 spaCy_T28 conj apolipoproteins,lipids
spaCy_R31 spaCy_T31 spaCy_T23 ccomp follow,determine
spaCy_R32 spaCy_T32 spaCy_T33 amod intensified,control
spaCy_R33 spaCy_T33 spaCy_T31 dobj control,follow
spaCy_R34 spaCy_T34 spaCy_T31 advcl using,follow
spaCy_R35 spaCy_T35 spaCy_T36 amod preprandial,doses
spaCy_R36 spaCy_T36 spaCy_T34 dobj doses,using
spaCy_R37 spaCy_T37 spaCy_T36 prep of,doses
spaCy_R38 spaCy_T38 spaCy_T39 amod regular,insulin
spaCy_R39 spaCy_T39 spaCy_T37 pobj insulin,of
spaCy_R4 spaCy_T4 spaCy_T3 cc and,HDL-cholesterol
spaCy_R40 spaCy_T40 spaCy_T34 prep with,using
spaCy_R41 spaCy_T41 spaCy_T43 det an,dose
spaCy_R42 spaCy_T42 spaCy_T43 amod additional,dose
spaCy_R43 spaCy_T43 spaCy_T40 pobj dose,with
spaCy_R44 spaCy_T44 spaCy_T43 prep of,dose
spaCy_R45 spaCy_T45 spaCy_T46 compound NPH,insulin
spaCy_R46 spaCy_T46 spaCy_T44 pobj insulin,of
spaCy_R47 spaCy_T47 spaCy_T34 prep before,using
spaCy_R48 spaCy_T48 spaCy_T47 pobj bedtime,before
spaCy_R49 spaCy_T49 spaCy_T21 punct .,studied
spaCy_R5 spaCy_T5 spaCy_T3 conj apolipoprotein,HDL-cholesterol
spaCy_R50 spaCy_T50 spaCy_T54 det The,dose
spaCy_R51 spaCy_T51 spaCy_T54 amod mean,dose
spaCy_R52 spaCy_T52 spaCy_T54 amod total,dose
spaCy_R53 spaCy_T53 spaCy_T54 compound dialy,dose
spaCy_R54 spaCy_T54 spaCy_T58 nsubjpass dose,increased
spaCy_R55 spaCy_T55 spaCy_T54 prep of,dose
spaCy_R56 spaCy_T56 spaCy_T55 pobj insulin,of
spaCy_R57 spaCy_T57 spaCy_T58 auxpass was,increased
spaCy_R58 spaCy_T58 spaCy_T58 ROOT increased,increased
spaCy_R59 spaCy_T59 spaCy_T58 prep from,increased
spaCy_R6 spaCy_T6 spaCy_T1 conj A-I,levels
spaCy_R60 spaCy_T60 spaCy_T70 quantmod 1.03,0.44
spaCy_R61 spaCy_T61 spaCy_T70 quantmod +,0.44
spaCy_R62 spaCy_T62 spaCy_T70 punct /,0.44
spaCy_R63 spaCy_T63 spaCy_T62 punct -,/
spaCy_R64 spaCy_T64 spaCy_T66 quantmod 0.09,1.17
spaCy_R65 spaCy_T65 spaCy_T66 quantmod to,1.17
spaCy_R66 spaCy_T66 spaCy_T70 quantmod 1.17,0.44
spaCy_R67 spaCy_T67 spaCy_T70 quantmod +,0.44
spaCy_R68 spaCy_T68 spaCy_T70 punct /,0.44
spaCy_R69 spaCy_T69 spaCy_T70 punct -,0.44
spaCy_R7 spaCy_T7 spaCy_T1 prep after,levels
spaCy_R70 spaCy_T70 spaCy_T71 nummod 0.44,units/kg
spaCy_R71 spaCy_T71 spaCy_T59 pobj units/kg,from
spaCy_R72 spaCy_T72 spaCy_T58 prep throughout,increased
spaCy_R73 spaCy_T73 spaCy_T75 det the,period
spaCy_R74 spaCy_T74 spaCy_T75 amod six-month,period
spaCy_R75 spaCy_T75 spaCy_T72 pobj period,throughout
spaCy_R76 spaCy_T76 spaCy_T58 punct .,increased
spaCy_R77 spaCy_T77 spaCy_T83 nsubj Levels,increased
spaCy_R78 spaCy_T78 spaCy_T77 prep of,Levels
spaCy_R79 spaCy_T79 spaCy_T78 pobj HDL-cholesterol,of
spaCy_R8 spaCy_T8 spaCy_T10 amod intensified,therapy
spaCy_R80 spaCy_T80 spaCy_T79 cc and,HDL-cholesterol
spaCy_R81 spaCy_T81 spaCy_T82 compound apolipoprotein,A-I
spaCy_R82 spaCy_T82 spaCy_T83 nsubj A-I,increased
spaCy_R83 spaCy_T83 spaCy_T83 ROOT increased,increased
spaCy_R84 spaCy_T84 spaCy_T83 prep without,increased
spaCy_R85 spaCy_T85 spaCy_T86 amod significant,changes
spaCy_R86 spaCy_T86 spaCy_T84 pobj changes,without
spaCy_R87 spaCy_T87 spaCy_T86 prep in,changes
spaCy_R88 spaCy_T88 spaCy_T89 compound hemoglobin,A1
spaCy_R89 spaCy_T89 spaCy_T87 pobj A1,in
spaCy_R9 spaCy_T9 spaCy_T10 compound insulin,therapy
spaCy_R90 spaCy_T90 spaCy_T89 punct (,A1
spaCy_R91 spaCy_T91 spaCy_T89 appos HbA1,A1
spaCy_R92 spaCy_T92 spaCy_T89 punct ),A1
spaCy_R93 spaCy_T93 spaCy_T89 punct ",",A1
spaCy_R94 spaCy_T94 spaCy_T89 conj triglyceride,A1
spaCy_R95 spaCy_T95 spaCy_T94 punct ",",triglyceride
spaCy_R96 spaCy_T96 spaCy_T94 cc or,triglyceride
spaCy_R97 spaCy_T97 spaCy_T94 conj cholesterol,triglyceride
spaCy_R98 spaCy_T98 spaCy_T83 punct .,increased
spaCy_R99 spaCy_T99 spaCy_T100 det These,findings